chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Increasing dizziness; Vertigo symptoms; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Increasing dizziness) and VERTIGO (Vertigo symptoms) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 immunisation.     The patient's medical history was not reported.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Antidepressant therapy, TRAZODONE for Sleep problem, LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DIZZINESS (Increasing dizziness) and VERTIGO (Vertigo symptoms). At the time of the report, DIZZINESS (Increasing dizziness) and VERTIGO (Vertigo symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient did not use any treatment medication. It was reported that the severity of events was 2/10 first and then at the time of report it was 5/10, gets better with the movement and had started to disrupt daily activities.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hypersomnia, Myalgia, Vaccination site warmth
Clinical narrative: Injection site was hot to touch and it was 100.8°F; Slept a lot; Body aches; Chills; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE WARMTH (Injection site was hot to touch and it was 100.8°F), HYPERSOMNIA (Slept a lot), MYALGIA (Body aches) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site was hot to touch and it was 100.8°F), HYPERSOMNIA (Slept a lot), MYALGIA (Body aches) and CHILLS (Chills). At the time of the report, VACCINATION SITE WARMTH (Injection site was hot to touch and it was 100.8°F), HYPERSOMNIA (Slept a lot), MYALGIA (Body aches) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Treatment medications were unknown.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events are not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Malaise, Pyrexia
Clinical narrative: Felt terrible all over; Bad headache; Fever; Flu like symptoms; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), MALAISE (Felt terrible all over), HEADACHE (Bad headache) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Bad headache) and PYREXIA (Fever). On an unknown date, the patient experienced MALAISE (Felt terrible all over). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), MALAISE (Felt terrible all over), HEADACHE (Bad headache) and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported No treatment medication were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, SARS-CoV-2 test
Clinical narrative: fever; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (they had COVID diagnosis, testing and symptoms on 01Dec2020) on 01-Dec-2020.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 14-Jan-2021, the patient experienced PYREXIA (fever). At the time of the report, PAIN IN EXTREMITY (sore arm) and PYREXIA (fever) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Dec-2020, SARS-CoV-2 test: positive.         No concomitant medications were provided.  No treatment information provided
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Peripheral swelling, Pyrexia
Clinical narrative: Swollen arm; 102 degree fever; Chills 3 hours after the shot; This spontaneous case was reported by an other health care professional and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), PYREXIA (102 degree fever) and CHILLS (Chills 3 hours after the shot) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm), PYREXIA (102 degree fever) and CHILLS (Chills 3 hours after the shot). At the time of the report, PERIPHERAL SWELLING (Swollen arm), PYREXIA (102 degree fever) and CHILLS (Chills 3 hours after the shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 degree (High) Pyrexia.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. Treatment information was not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Dizziness, Eye pruritus
Clinical narrative: sore throat; diarrhea; shooting pains in her body; eyes hurt; felt nauseous; CHILLS; FEVER; aches in her joints; aches in her muscles; headache; fatigue; became very ill; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (became very ill), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (sore throat), DIARRHOEA (diarrhea) and PAIN (shooting pains in her body) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced ILLNESS (became very ill), DIZZINESS (Dizziness), PAIN (shooting pains in her body), EYE PRURITUS (eyes hurt), NAUSEA (felt nauseous), CHILLS (CHILLS), PYREXIA (FEVER), ARTHRALGIA (aches in her joints), MYALGIA (aches in her muscles), HEADACHE (headache) and FATIGUE (fatigue). On 30-Jan-2021, the patient experienced DIARRHOEA (diarrhea). On 31-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). On 30-Jan-2021, ILLNESS (became very ill), PAIN (shooting pains in her body), EYE PRURITUS (eyes hurt), NAUSEA (felt nauseous), PYREXIA (FEVER), ARTHRALGIA (aches in her joints), MYALGIA (aches in her muscles) and HEADACHE (headache) had resolved. At the time of the report, DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (sore throat) and DIARRHOEA (diarrhea) outcome was unknown and CHILLS (CHILLS) and FATIGUE (fatigue) had resolved. Not Provided          No concomitant medications were provided Treatment included Tylenol, Ibuprofen.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Illness, Myalgia, Nausea
Clinical narrative: sore throat; diarrhea; shooting pains in her body; eyes hurt; felt nauseous; CHILLS; FEVER; aches in her joints; aches in her muscles; headache; fatigue; became very ill; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (became very ill), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (sore throat), DIARRHOEA (diarrhea) and PAIN (shooting pains in her body) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced ILLNESS (became very ill), DIZZINESS (Dizziness), PAIN (shooting pains in her body), EYE PRURITUS (eyes hurt), NAUSEA (felt nauseous), CHILLS (CHILLS), PYREXIA (FEVER), ARTHRALGIA (aches in her joints), MYALGIA (aches in her muscles), HEADACHE (headache) and FATIGUE (fatigue). On 30-Jan-2021, the patient experienced DIARRHOEA (diarrhea). On 31-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). On 30-Jan-2021, ILLNESS (became very ill), PAIN (shooting pains in her body), EYE PRURITUS (eyes hurt), NAUSEA (felt nauseous), PYREXIA (FEVER), ARTHRALGIA (aches in her joints), MYALGIA (aches in her muscles) and HEADACHE (headache) had resolved. At the time of the report, DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (sore throat) and DIARRHOEA (diarrhea) outcome was unknown and CHILLS (CHILLS) and FATIGUE (fatigue) had resolved. Not Provided          No concomitant medications were provided Treatment included Tylenol, Ibuprofen.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: sore throat; diarrhea; shooting pains in her body; eyes hurt; felt nauseous; CHILLS; FEVER; aches in her joints; aches in her muscles; headache; fatigue; became very ill; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (became very ill), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (sore throat), DIARRHOEA (diarrhea) and PAIN (shooting pains in her body) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced ILLNESS (became very ill), DIZZINESS (Dizziness), PAIN (shooting pains in her body), EYE PRURITUS (eyes hurt), NAUSEA (felt nauseous), CHILLS (CHILLS), PYREXIA (FEVER), ARTHRALGIA (aches in her joints), MYALGIA (aches in her muscles), HEADACHE (headache) and FATIGUE (fatigue). On 30-Jan-2021, the patient experienced DIARRHOEA (diarrhea). On 31-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). On 30-Jan-2021, ILLNESS (became very ill), PAIN (shooting pains in her body), EYE PRURITUS (eyes hurt), NAUSEA (felt nauseous), PYREXIA (FEVER), ARTHRALGIA (aches in her joints), MYALGIA (aches in her muscles) and HEADACHE (headache) had resolved. At the time of the report, DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (sore throat) and DIARRHOEA (diarrhea) outcome was unknown and CHILLS (CHILLS) and FATIGUE (fatigue) had resolved. Not Provided          No concomitant medications were provided Treatment included Tylenol, Ibuprofen.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Rash, Vaccination site erythema, Vaccination site pain
Clinical narrative: Rash on abdomen, back and underarm; Redness at the injection site "like a ring" or like "mosquito bite", swollen up from the injection site; Strong pain on the injection site; Redness at the injection site; Swelling at the injection site; Low fever; Chills; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of RASH (Rash on abdomen, back and underarm), VACCINATION SITE URTICARIA (Redness at the injection site "like a ring" or like "mosquito bite", swollen up from the injection site), VACCINATION SITE PAIN (Strong pain on the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Swelling at the injection site) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rash on abdomen, back and underarm), VACCINATION SITE URTICARIA (Redness at the injection site "like a ring" or like "mosquito bite", swollen up from the injection site), VACCINATION SITE PAIN (Strong pain on the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), PYREXIA (Low fever) and CHILLS (Chills). At the time of the report, RASH (Rash on abdomen, back and underarm), VACCINATION SITE URTICARIA (Redness at the injection site "like a ring" or like "mosquito bite", swollen up from the injection site), VACCINATION SITE PAIN (Strong pain on the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), PYREXIA (Low fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant medications were not reported.  Treatment information was not provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site urticaria
Clinical narrative: Rash on abdomen, back and underarm; Redness at the injection site "like a ring" or like "mosquito bite", swollen up from the injection site; Strong pain on the injection site; Redness at the injection site; Swelling at the injection site; Low fever; Chills; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of RASH (Rash on abdomen, back and underarm), VACCINATION SITE URTICARIA (Redness at the injection site "like a ring" or like "mosquito bite", swollen up from the injection site), VACCINATION SITE PAIN (Strong pain on the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Swelling at the injection site) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rash on abdomen, back and underarm), VACCINATION SITE URTICARIA (Redness at the injection site "like a ring" or like "mosquito bite", swollen up from the injection site), VACCINATION SITE PAIN (Strong pain on the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), PYREXIA (Low fever) and CHILLS (Chills). At the time of the report, RASH (Rash on abdomen, back and underarm), VACCINATION SITE URTICARIA (Redness at the injection site "like a ring" or like "mosquito bite", swollen up from the injection site), VACCINATION SITE PAIN (Strong pain on the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), PYREXIA (Low fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant medications were not reported.  Treatment information was not provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Myalgia, SARS-CoV-2 test
Clinical narrative: COVID-19 diagnose after first shot; Body aches; Headache; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (COVID-19 diagnose after first shot), MYALGIA (Body aches) and HEADACHE (Headache) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced MYALGIA (Body aches) and HEADACHE (Headache). On 24-Jan-2021, the patient experienced COVID-19 (COVID-19 diagnose after first shot). The patient was treated with PARACETAMOL (TYLENOL) for Myalgia and Headache, at a dose of 1 dosage form and VITAMINS NOS for Myalgia and Headache, at a dose of 1 dosage form. At the time of the report, COVID-19 (COVID-19 diagnose after first shot), MYALGIA (Body aches) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, SARS-CoV-2 test: negative (Negative) Negative. On 24-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   When asked about concomitant medications patient mentioned she only consumes vitamins
Sex: M
Vaccine: COVID19
Symptoms: Insomnia
Clinical narrative: not been able to sleep at night since 2 entire night of insomnia; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (not been able to sleep at night since 2 entire night of insomnia) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (not been able to sleep at night since 2 entire night of insomnia). At the time of the report, INSOMNIA (not been able to sleep at night since 2 entire night of insomnia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Pain
Clinical narrative: Shot it settled in his spine and caused pain making it hard to walk; Shot it settled in his spine and caused pain making it hard to walk; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Shot it settled in his spine and caused pain making it hard to walk) and GAIT DISTURBANCE (Shot it settled in his spine and caused pain making it hard to walk) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN (Shot it settled in his spine and caused pain making it hard to walk) and GAIT DISTURBANCE (Shot it settled in his spine and caused pain making it hard to walk). At the time of the report, PAIN (Shot it settled in his spine and caused pain making it hard to walk) and GAIT DISTURBANCE (Shot it settled in his spine and caused pain making it hard to walk) outcome was unknown. Not Provided   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.  No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Diarrhoea, Pain in extremity, Pyrexia
Clinical narrative: diarrhea (that is not there anymore but he keeps farting); Pain in arm; fever (up to 103°F); This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea (that is not there anymore but he keeps farting)), PAIN IN EXTREMITY (Pain in arm) and PYREXIA (fever (up to 103°F)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea (that is not there anymore but he keeps farting)), PAIN IN EXTREMITY (Pain in arm) and PYREXIA (fever (up to 103°F)). At the time of the report, DIARRHOEA (diarrhea (that is not there anymore but he keeps farting)), PAIN IN EXTREMITY (Pain in arm) and PYREXIA (fever (up to 103°F)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Body temperature: 103°f. (High) degree Celsius. On 03-Feb-2021, Body temperature: 100°f. (High) degree Celsius.   Concomitant products were not provided/unknown.  Treatment medications were not reported/unknown.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Headache, Nausea, Pain
Clinical narrative: ACID) for Product for unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced BONE PAIN (Pain in the bones), PAIN (Body ache), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, BONE PAIN (Pain in the bones), PAIN (Body ache), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: ACID) for Product for unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced BONE PAIN (Pain in the bones), PAIN (Body ache), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, BONE PAIN (Pain in the bones), PAIN (Body ache), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives on both arms; This spontaneous case was reported by a patient family member or friend and describes the occurrence of URTICARIA (hives on both arms) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included ALLOPURINOL, SIMVASTATIN, DONEPEZIL, CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]) and MELATONIN for an unknown indication.  On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced URTICARIA (hives on both arms). At the time of the report, URTICARIA (hives on both arms) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient took Benadryl (diphenhydramine).   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow up was received on 20 Apr 2021 included no additional information.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Injection site redness; Swollen injection site; Fever of 101 Degrees Fahrenheit/Fever of 103 Degrees Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE SWELLING (Swollen injection site) and PYREXIA (Fever of 101 Degrees Fahrenheit/Fever of 103 Degrees Fahrenheit) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020. Concomitant products included IBUPROFEN for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE SWELLING (Swollen injection site) and PYREXIA (Fever of 101 Degrees Fahrenheit/Fever of 103 Degrees Fahrenheit). At the time of the report, VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE SWELLING (Swollen injection site) and PYREXIA (Fever of 101 Degrees Fahrenheit/Fever of 103 Degrees Fahrenheit) outcome was unknown.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Body temperature: 103 (High) 103 degree Fahrenheit.   mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Follow up included medical history added, contact information was added
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Pain in extremity, Vaccination site erythema
Clinical narrative: again struggling with nausea and diarrhea; again struggling with nausea and diarrhea; nausea and diarrhea has been on and off; nausea and diarrhea has been on and off; redness at the lower deltoid attachment/two silver dollar sized red rashes at the lower deltoid attachment; left arm went back to being "a little sore"; left arm was "pretty sore"; left arm was "a little sore"; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (left arm was "a little sore"), PAIN IN EXTREMITY (left arm was "pretty sore"), PAIN IN EXTREMITY (left arm went back to being "a little sore"), DIARRHOEA (nausea and diarrhea has been on and off) and DIARRHOEA (again struggling with nausea and diarrhea) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 08-Jan-2021, the patient experienced PAIN IN EXTREMITY (left arm was "a little sore"). On 09-Jan-2021, the patient experienced PAIN IN EXTREMITY (left arm was "pretty sore"). On 10-Jan-2021, the patient experienced PAIN IN EXTREMITY (left arm went back to being "a little sore"). On 11-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at the lower deltoid attachment/two silver dollar sized red rashes at the lower deltoid attachment). On 20-Jan-2021, the patient experienced DIARRHOEA (nausea and diarrhea has been on and off) and NAUSEA (nausea and diarrhea has been on and off). On 03-Feb-2021, the patient experienced DIARRHOEA (again struggling with nausea and diarrhea) and NAUSEA (again struggling with nausea and diarrhea). At the time of the report, PAIN IN EXTREMITY (left arm was "a little sore"), PAIN IN EXTREMITY (left arm was "pretty sore"), PAIN IN EXTREMITY (left arm went back to being "a little sore"), DIARRHOEA (nausea and diarrhea has been on and off), DIARRHOEA (again struggling with nausea and diarrhea), VACCINATION SITE ERYTHEMA (redness at the lower deltoid attachment/two silver dollar sized red rashes at the lower deltoid attachment), NAUSEA (nausea and diarrhea has been on and off) and NAUSEA (again struggling with nausea and diarrhea) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Insomnia, Pyrexia
Clinical narrative: Can not sleep; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Can not sleep), CHILLS (Chills) and PYREXIA (Fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced INSOMNIA (Can not sleep), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, INSOMNIA (Can not sleep), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.      Concomitant product use was not provided by the reporter.  No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Reaction that is reddish to pinkish in color; Little itchy; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Reaction that is reddish to pinkish in color) and PRURITUS (Little itchy) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 05J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Reaction that is reddish to pinkish in color) and PRURITUS (Little itchy). At the time of the report, ERYTHEMA (Reaction that is reddish to pinkish in color) and PRURITUS (Little itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Pyrexia, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Injection site itching; Injection site aching, injection site soreness; Felt a little feverish; Feeling a little fatigued; Sore arm; A spontaneous report was received from a consumer, concerning herself, a 70-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 22 Jan 2021, 1 day prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) for prophylaxis of COVID-19 infection.  On 22 Jan 2021 (friday), the patient experienced sore arm and felt little fatigued, had nothing else apart from this. On 29 Jan 2021, through Saturday 30 Jan 2021, the patient experienced injection site aching, injection site soreness, injection site itching and felt a little feverish. No treatment information was provided.  Action taken with mRNA-1273 in response to the events were not reported.  The outcome of the sore arm, feeling a little fatigued, Injection site aching, injection site soreness, injection site itching and felt a little feverish were considered not resolved at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Peripheral swelling, Pyrexia, Rash
Clinical narrative: Arm swelled up; Patch; Chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swelled up), RASH (Patch), CHILLS (Chills) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm swelled up), RASH (Patch), CHILLS (Chills) and PYREXIA (fever). On 25-Jan-2021, CHILLS (Chills) and PYREXIA (fever) had resolved. At the time of the report, PERIPHERAL SWELLING (Arm swelled up) and RASH (Patch) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Relevant medical history not reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not reported.   Treatment information was not reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Vaccination site erythema, Vaccination site pain
Clinical narrative: arm slightly inflamed; big red blotch about 3' in diameter; Arm ached; This spontaneous case was reported by a patient and describes the occurrence of INFLAMMATION (arm slightly inflamed), VACCINATION SITE PAIN (Arm ached) and VACCINATION SITE ERYTHEMA (big red blotch about 3' in diameter) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension. Concomitant products included ENALAPRIL for Hypertension.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm ached). On 04-Feb-2021, the patient experienced INFLAMMATION (arm slightly inflamed) and VACCINATION SITE ERYTHEMA (big red blotch about 3' in diameter). The patient was treated with NAPROXEN SODIUM (ALEVE) on 04-Feb-2021 for Pain, at a dose of 2 UNK. On 21-Jan-2021, VACCINATION SITE PAIN (Arm ached) had resolved. At the time of the report, INFLAMMATION (arm slightly inflamed) and VACCINATION SITE ERYTHEMA (big red blotch about 3' in diameter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: got shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (got shingles) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced HERPES ZOSTER (got shingles). At the time of the report, HERPES ZOSTER (got shingles) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Today the redness has come down to my arm, it's spreading.; Yesterday I looked at it and there was a red area there; my shoulder started itching.; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (Today the redness has come down to my arm, it's spreading.), VACCINATION SITE PRURITUS (my shoulder started itching.) and VACCINATION SITE ERYTHEMA (Yesterday I looked at it and there was a red area there) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal (Patient takes unspecified blood pressure medicine every morning) and Macular degeneration (Patient mentioned she uses vitamins for macular degeneration). Concomitant products included VITAMINS NOS for Macular degeneration.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (my shoulder started itching.). On 03-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Yesterday I looked at it and there was a red area there). On 04-Feb-2021, the patient experienced ERYTHEMA (Today the redness has come down to my arm, it's spreading.). At the time of the report, ERYTHEMA (Today the redness has come down to my arm, it's spreading.), VACCINATION SITE PRURITUS (my shoulder started itching.) and VACCINATION SITE ERYTHEMA (Yesterday I looked at it and there was a red area there) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       In addition to taking vitamins for macular degeneration as noted above, the patient reported taking an unspecified blood pressure medication every morning per source document.   Treatment for the events included use of hydrocortisone cream and diphenhydramine (Benadryl) cream as prescribed by the patient's doctor.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Toothache
Clinical narrative: toothache; sore arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (toothache), PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and COPD. Concomitant products included UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (ANORO) for COPD, LISINOPRIL for Hypertension.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced TOOTHACHE (toothache), PAIN IN EXTREMITY (sore arm) and HEADACHE (headache). At the time of the report, TOOTHACHE (toothache), PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment information was not provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Injection site was itchy; Injection site was red; Had discomfort first few days; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Had discomfort first few days), VACCINATION SITE PRURITUS (Injection site was itchy) and VACCINATION SITE ERYTHEMA (Injection site was red) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included Crohn's disease. Concurrent medical conditions included Blood pressure high.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced DISCOMFORT (Had discomfort first few days). On 31-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site was itchy) and VACCINATION SITE ERYTHEMA (Injection site was red). At the time of the report, DISCOMFORT (Had discomfort first few days), VACCINATION SITE PRURITUS (Injection site was itchy) and VACCINATION SITE ERYTHEMA (Injection site was red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive after getting the Moderna COVID 19 vaccine; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of COVID-19 (Tested positive after getting the Moderna COVID 19 vaccine) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced COVID-19 (Tested positive after getting the Moderna COVID 19 vaccine). At the time of the report, COVID-19 (Tested positive after getting the Moderna COVID 19 vaccine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications have not been provided.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Non significant follow up received as email response
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Nausea, Pain
Clinical narrative: Body Aches Mild-Moderate; Headache Mild-Moderate; Feeling Queasy; Pain Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body Aches Mild-Moderate), HEADACHE (Headache Mild-Moderate), NAUSEA (Feeling Queasy) and INJECTION SITE PAIN (Pain Injection Site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 000K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (Body Aches Mild-Moderate), HEADACHE (Headache Mild-Moderate), NAUSEA (Feeling Queasy) and INJECTION SITE PAIN (Pain Injection Site). At the time of the report, PAIN (Body Aches Mild-Moderate), HEADACHE (Headache Mild-Moderate), NAUSEA (Feeling Queasy) and INJECTION SITE PAIN (Pain Injection Site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Pulmonary pain
Clinical narrative: felt hard to breath/feels like someone punching him; lung so sore inside; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (felt hard to breath/feels like someone punching him) and PULMONARY PAIN (lung so sore inside) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Lymphoma (non-Hodgkin's) and Blood pressure high. Concomitant products included RITUXIMAB (RITUXAN), ACICLOVIR SODIUM (ACYCLOVIR ABBOTT VIAL) and ATORVASTATIN for an unknown indication.    On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced DYSPNOEA (felt hard to breath/feels like someone punching him) and PULMONARY PAIN (lung so sore inside). At the time of the report, DYSPNOEA (felt hard to breath/feels like someone punching him) and PULMONARY PAIN (lung so sore inside) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.